Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Blood Advances|June 8, 2021
Axicabtagene ciloleucel in vivo expansion and treatment outcome in aggressive B-cell lymphoma in a real-world settingFrancis A Ayuk, Carolina Berger, Anita Badbaran, et al.
Oncoimmunology|March 5, 2016
Comparison of naïve and central memory derived CD8+ effector cell engraftment fitness and function following adoptive transferXiuli Wang, ChingLam W Wong, Ryan Urak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2016
Analysis of ROR1 Protein Expression in Human Cancer and Normal TissuesAshwini Balakrishnan, Tracy Goodpaster, Julie Randolph-Habecker, et al.
Plos One|December 21, 2013
Combining a CD20 chimeric antigen receptor and an inducible caspase 9 suicide switch to improve the efficacy and safety of T cell adoptive immunotherapy for lymphomaLihua E Budde, Carolina Berger, Yukang Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2016
Preclinical Assessment of CD171-Directed CAR T-cell Adoptive Therapy for Childhood Neuroblastoma: CE7 Epitope Target Safety and Product Manufacturing FeasibilityAnnette Künkele, Agne Taraseviciute, Laura S Finn, et al.
Bone Marrow Transplantation|November 27, 2025
Comparison of anti-human T cell globulins on immune reconstitution and early infections after autologous transplant in patients with multiple sclerosisJohanna Richter, Nico Gagelmann, Felix Fischbach, et al.
Med (New York, N.Y.)|March 30, 2024
CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosisFelix Fischbach, Johanna Richter, Lena Kristina Pfeffer, et al.
Science Translational Medicine|September 9, 2016
Immunotherapy of non-Hodgkin's lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cellsCameron J Turtle, Laïla-Aïcha Hanafi, Carolina Berger, et al.
Haematologica|August 11, 2022
Molecular monitoring of T-cell kinetics and migration in severe neurotoxicity after real-world CD19-specific chimeric antigen receptor T cell therapySusanna Carolina Berger, Boris Fehse, Nuray Akyüz, et al.
International Journal of Oncology|March 16, 2022
Comparison of single copy gene‑based duplex quantitative PCR and digital droplet PCR for monitoring of expansion of CD19‑directed CAR T cells in treated patientsMaria-Luisa Schubert, Carolina Berger, Alexander Kunz, et al.
Pageof 4